New Self-Test could slash cervical cancer rates in developing nations
NCT ID NCT07232355
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in Honduras tests a new way to prevent cervical cancer using a self-collected HPV test that gives results in under an hour, combined with AI-powered imaging. 5,000 women will participate to see if this same-day screening-and-treatment approach is accurate, feasible, and cost-effective. The goal is to make screening easier and reduce the number of women who miss follow-up care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AmpFire® HPV test (self-sampling kit) and Automated Visual Evaluation (AI imaging)
What this could lead to
If successful, this approach could make cervical cancer screening faster, cheaper, and more accessible in low-resource countries, potentially preventing many cases.
What could go wrong
This is a large feasibility study, not a final proof of cure. The test and AI triage may not perform as expected in real-world settings, and cost-effectiveness remains to be proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atila Biosystems, Inc.
RECRUITINGSunnyvale, California, 94085, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Basic Health International
RECRUITINGSan Salvador, El Salvador
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centro de Salud Las Crucitas
RECRUITINGTegucigalpa, Honduras
Contact Email: •••••@•••••
-
Ciudad Mujer Kennedy
RECRUITINGTegucigalpa, Honduras
Contact Email: •••••@•••••